Delivery Order SPE2DB20D2104-SPE2DB21FS71C

Award Date 5/11/21
Potential Completion Date 5/12/21
Potential Value $1.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chesterbrook, PA, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) is for a Firm Fixed Price Delivery Order with Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a Prime Vendor Pharmaceutical Branch in Philadelphia. The contract has a ceiling value of $7,719.54 and a performance period through May 17, 2021. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Amerisourcebergen, valued at up to...
This federal contract award is for a Delivery Order (SPE2DB20D3101|SPE2DB21FJ3D6) with a Ceiling Value of $1,062.12, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for "PRIME VENDOR PHARM BRANCH-PHILADELPHIA" and has an Ultimate Completion Date of April 21, 2021. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that...
This federal contract award is for a delivery order with a ceiling value of $2,157.60 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for "PRIME VENDOR PHARM BRANCH-PHILADELPHIA" and has an ultimate completion date of September 11, 2020. The contract is a firm fixed-price Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that runs through November 2026....
This federal contract award is for a Delivery Order worth $4,734.72 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for "PRIME VENDOR PHARM BRANCH-PHILADELPHIA". The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of May 18, 2021. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
This federal contract award is for a Delivery Order with a Firm Fixed Price contract type, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,066.45 and an ultimate completion date of July 17, 2020. The contract is for the provision of "PRIME VENDOR PHARM BRANCH-PHILADELPHIA", which indicates the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military and government...
This federal contract award from the Defense Logistics Agency (DLA) is a Delivery Order valued at $8,352.60 issued to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for a Prime Vendor Pharmaceutical Branch-Philadelphia, with an ultimate completion date of April 23, 2021. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical,...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a Prime Vendor Pharmaceutical Branch - Philadelphia. The contract was awarded by the Defense Logistics Agency (DLA) and is a Delivery Order valued at $2,405.55. It has an ultimate completion date of January 22, 2021. The contract provides for the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans'...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999. The award, with a ceiling value of $32,804.38, is for the Prime Vendor Pharmaceutical Branch in Philadelphia, encompassing a broad range of pharmaceutical products and medical supplies to support military and veteran healthcare programs. The contract...
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order valued at $19,374.65 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for providing a prime vendor pharmaceutical supply for the DLA Troop Support Medical branch in Philadelphia. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, that runs through November 2026. The IDC serves as the...
This federal contract award is a delivery order valued at $34,010.64, issued to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA). The order is for a Prime Vendor Pharmaceutical Branch in Philadelphia, with an ultimate completion date of March 31, 2021. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB21FS71C
    Delivery Order

This federal contract award is for a Delivery Order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a "Prime Vendor Pharm Branch-Philadelphia" for the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,077.12 and was awarded on May 11, 2021, with an ultimate completion date of May 12, 2021. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC allows the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The contract does not have a set-aside designation, indicating full and open competition.

Generated 2/27/25, 9:48 AM